1,25-dihydroxyergocalciferol and Hypophosphatemia

1,25-dihydroxyergocalciferol has been researched along with Hypophosphatemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Demura, H; Kazama, J; Kobayashi, T; Nohtomi, K; Ozawa, H; Sato, K; Takeuchi, A	1

Other Studies

1 other study(ies) available for 1,25-dihydroxyergocalciferol and Hypophosphatemia

Article	Year
Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules. Bone, 1997, Volume: 21, Issue:1 Topics: Alkaline Phosphatase; Animals; Bone Development; Calcitriol; Calcium; Dose-Response Relationship, Drug; Ergocalciferols; Ferric Compounds; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Hypophosphatemia; Injections, Intravenous; Kidney Tubules; Liver Cirrhosis; Male; Mice; Middle Aged; Osteomalacia; Pain; Parathyroid Hormone; Parietal Bone; Phosphates	1997

Article

Year

Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules.

Bone, 1997, Volume: 21, Issue:1

Topics: Alkaline Phosphatase; Animals; Bone Development; Calcitriol; Calcium; Dose-Response Relationship, Drug; Ergocalciferols; Ferric Compounds; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Hypophosphatemia; Injections, Intravenous; Kidney Tubules; Liver Cirrhosis; Male; Mice; Middle Aged; Osteomalacia; Pain; Parathyroid Hormone; Parietal Bone; Phosphates

1997